Cancer Biology and Therapeutics
A section of Biomedicines (ISSN 2227-9059).
Section Information
Scope
This section publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, a better understanding of the interrelations between cancer and metabolism as well as tumor and microenvironment, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Pathogenesis and Treatment of Adrenal Tumors 2.0 (Deadline: 31 October 2023)
- Advances in Urothelial Cancer Volume II (Deadline: 31 October 2023)
- Therapeutic Potential of Nerve Growth Factor Signaling Blockers against Castration-Resistant Prostate Cancers (Deadline: 31 October 2023)
- New Biomarkers in Thyroid Cancer and Autoimmune Diseases (Deadline: 31 October 2023)
- Advanced Research in Endocrine Tumor: Molecular Pathology, Biomarker and Target Therapy 2.0 (Deadline: 31 October 2023)
- The Role of Inflammatory Cytokines in Cancer Progression 2.0 (Deadline: 31 October 2023)
- Pathogenesis and Novel Therapies of Acute Leukemias (Deadline: 31 October 2023)
- Mechanism and Novel Therapeutic Approaches for Non-small Cell Lung Cancer (Deadline: 31 October 2023)
- Killing It Softly–New Approaches to Overcome Cancer Chemoresistance 2.0 (Deadline: 31 October 2023)
- Advances in the Treatment of Kidney and Upper Urinary Tract Cancers (Deadline: 31 October 2023)
- The Role of DNA Repair in the Treatment of Ovarian and Breast Cancer (Deadline: 31 October 2023)
- Proteomics and Its Applications in Cancer (Deadline: 31 October 2023)
- Tumor Microenvironment and Cancer Therapy (Deadline: 31 October 2023)
- Novel Strategy for Treating Castration-Resistant Prostate Cancer (Volume II) (Deadline: 31 October 2023)
- Pathological Features and Genetic Research on Gastrointestinal Cancer (Deadline: 15 November 2023)
- Hepatocellular Carcinoma: From Molecular Mechanisms to Novel Therapeutic Approaches (Deadline: 15 November 2023)
- Prostate Cancer: From Molecular Basis to Clinical Therapy (Deadline: 30 November 2023)
- Feature Reviews in Cancer Biomarkers (Deadline: 30 November 2023)
- Advances in the Pharmacology of Neuroendocrine Tumors (Deadline: 30 November 2023)
- Prostate Cancer: Molecular Imaging and Radionuclide Therapy (Deadline: 30 November 2023)
- Tumor Microenvironment: From Cellular Components to Therapeutic Perspectives (Deadline: 30 November 2023)
- Colorectal Cancer: New Diagnostic and Therapeutic Approaches 2.0 (Deadline: 30 November 2023)
- STAT3 in Carcinogenesis: Update from 1993 to Present (Deadline: 30 November 2023)
- Novel Approaches towards Targeted Head and Neck Cancer Therapies (Deadline: 30 November 2023)
- Recent Innovations in Precision Oncology: The Pathway toward a Patient-Tailored Approach (Deadline: 30 November 2023)
- Kinases and Other Molecular Targets in Cancer: Recent Advances, Therapeutic Opportunities, and Clinical Challenges (Deadline: 30 November 2023)
- New Insights into Breast Cancer Management: From Tumorigenesis to Personalized Treatments (Deadline: 30 November 2023)
- Understanding Cancer’s Inflammatory Crosstalk: The Potential for Precision Targeting (Deadline: 30 November 2023)
- Gastrointestinal Cancers: From Diagnostics to Novel Therapeutic Approaches (Deadline: 30 November 2023)
- RAS Signaling in Cancer (Deadline: 30 November 2023)
- Gastric Cancer: From Pathophysiologic Mechanisms to Therapeutic Strategies (Deadline: 30 November 2023)
- Molecular and Cellular Research on Lung Cancer: A Development toward Precision Medicine (Deadline: 30 November 2023)
- New Insights into Upper Tract Urothelial Carcinoma: What Changed? (Deadline: 30 November 2023)
- Advances in Targeting Genomics and the Tumor Immune System to Treat Gastrointestinal Cancers (Deadline: 30 November 2023)
- Application of Liposomes in Cancer (Deadline: 30 November 2023)
- The Biology of Circulating Tumor Cells 2.0 (Deadline: 15 December 2023)
- Individualized Cancer Prevention and Management (Deadline: 15 December 2023)
- Resistance to Targeted Therapies in Human Cancer 2.0 (Deadline: 15 December 2023)
- Oral Squamous Cell Carcinoma: Molecular Signaling Pathways and Novel Biomarkers (Deadline: 15 December 2023)
- Breast Cancer: Novel Biomarkers for Diagnosis and Therapy (Deadline: 15 December 2023)
- Advancements in Synthetic Small Molecules as Anti-cancer Therapeutics (Deadline: 15 December 2023)
- Feature Reviews in Molecular Mechanisms of Head and Neck Cancers (Deadline: 30 December 2023)
- Signaling Pathways in Gynecological Malignant Tumors (Deadline: 31 December 2023)
- The Tumor Microenvironment in Colorectal Cancer: New Therapeutic Targets and Implications for Therapy Response (Deadline: 31 December 2023)
- Morphomolecular Characterization of Neoplastic and Pre-neoplastic Lesions in Solid Malignancies (Deadline: 31 December 2023)
- State of the Art and Future Perspectives in Oncologic Imaging (Deadline: 31 December 2023)
- Cellular and Metabolic Reprogramming in Cancer (Deadline: 31 December 2023)
- Intrinsic Metabolic Factors in Non-small Cell Lung Cancer (Deadline: 31 December 2023)
- Novel Insights on Cancer Stem Cells (Deadline: 31 December 2023)
- Molecular Targets in Cancer Cell Biology (Deadline: 31 December 2023)
- Editorial Board Members’ Collection Series: "Advances in Cancer Immunotherapy" (Deadline: 31 December 2023)
- Molecular Research on Colorectal Cancer (Deadline: 31 December 2023)
- Current Insights and Future Perspectives into Signaling Pathways and Mechanisms of Drug Resistance in Cancer (Deadline: 31 December 2023)
- Alternate Therapies and Proteomics/Genomics Studies of Cancer (Deadline: 31 December 2023)
- Advance in Antibody Based Cancer Therapy (Deadline: 31 December 2023)
- Evolving Landscape of DNA Repair in Cancer Therapy (Deadline: 31 December 2023)
- Tumor Viruses and Cancers: Carcinogenesis, Diagnosis, and Treatment Options (Deadline: 31 December 2023)
- Relationship between Gastrointestinal Tumors and the Immune Microenvironment (Deadline: 31 December 2023)
- Role of Chemoradiotherapy in Human Health and Disease (Deadline: 31 December 2023)
- COVID-19 Risk in Cancer Patients Receiving Immunotherapy (Deadline: 31 December 2023)
- Role of Autophagy in Cancer Physiological Mechanism (Deadline: 31 December 2023)
- Advancing Cancer Immunotherapy: Unleashing the Potential of the Immunological Synapse (Deadline: 31 December 2023)
- Bladder Cancer: Molecular Basis and Translational Research (Deadline: 31 December 2023)
- The Role of Gut Microbiota in Gastrointestinal Cancers: From Pathogenesis to Therapeutic Perspectives 2.0 (Deadline: 31 December 2023)
- Roles of T Cells in Immunotherapy (Deadline: 31 December 2023)
- Advances in Therapeutic Strategies in Gynecological Malignant Tumors (Deadline: 31 December 2023)
- Editorial Board Members’ Collection Series: "Cancer Biology and Therapeutics" (Deadline: 31 December 2023)
- Recent Advances in Lymphoma (Deadline: 31 December 2023)
- Advances in Immunotherapy and Radiation Therapy for Cancer (Deadline: 15 January 2024)
- Molecular Targets to Enhance the Radiation Effect and Overcome Radiation Resistance in Cancer (Deadline: 31 January 2024)
- Endometrial Cancer: From Pathobiology to Treatment (Deadline: 31 January 2024)
- State-of-the-Art Cancer Biology and Therapeutics in Poland Volume II (Deadline: 31 January 2024)
- Liver Cancer: From Molecular Mechanism to Therapeutic Perspectives (Deadline: 31 January 2024)
- Two Decades of Progress in the Prevention and Treatment of Colorectal Cancer: From Aspirin to Targeted Therapy (Deadline: 31 January 2024)
- Understanding Non-small Cell Lung Cancer: Biology, Therapeutics and Drug Resistance (Deadline: 31 January 2024)
- Epigenetic Regulation of Solid Tumors (Deadline: 31 January 2024)
- Pancreatic Cancer Heterogeneity and Therapeutic Implications (Deadline: 31 January 2024)
- Mechanisms and Novel Therapeutic Approaches for Colorectal Cancer (Deadline: 31 January 2024)
- Molecular Pathway Leading to Cancer Metastasis : Basic and Therapeutic Approach (Deadline: 31 January 2024)
- Establishment of State-of-the-Art Methods/Techniques and Identification of Novel Biomarkers in Brain Tumor Diagnosis (Deadline: 31 January 2024)
- Glioblastoma: Current Status and Future Prospects (Deadline: 31 January 2024)
- Advances in Molecular Mechanisms of Head and Neck Cancers (Deadline: 15 February 2024)
- Emerging Perspectives on Breast Cancer and Antibody–Drug Conjugates Treatment: From Bench to Bedside (Deadline: 29 February 2024)
- NASH and Hepatocellular Carcinoma (HCC) (Deadline: 29 February 2024)
- Metastatic Melanoma: Current Status and Future Prospects (Deadline: 29 February 2024)
- Predictive and Prognostic Biomarkers for Response to Neoadjuvant Chemotherapy-with and without HER2-Targeting Therapy (Deadline: 29 February 2024)
- Regulators of Cancer Metastasis (Deadline: 29 February 2024)
- Current Insights and Future Perspectives into Mechanisms of Drug Resistance in Gastrointestinal Cancers (Deadline: 29 February 2024)
- Cancer Immunotherapy: The Multiple Impacts of Tumor Microenvironment (Deadline: 29 February 2024)
- An Update on Mechanisms and Treatments for Thyroid Cancer in Current Oncology (Deadline: 29 February 2024)
- Molecular Research and New Therapy in Melanoma (Deadline: 29 February 2024)
- Head and Neck Tumors, 3rd Edition (Deadline: 29 February 2024)
- Biomarkers and Targeted Drugs for Colorectal Cancer (Deadline: 29 February 2024)
- State-of-the-Art Cancer Biology and Therapeutics in Italy (Deadline: 29 February 2024)
- Diagnostic, Prognostic and Predictive Biomarkers and New Targets for Treatment in Gastric Cancer (Deadline: 29 February 2024)
- Cancer Immunology: From Molecular Mechanisms to Therapeutic Target through Emerging In Vitro Approaches (Deadline: 29 February 2024)
- Molecular Biomarkers of Tumors: Advancing Genetic Studies (Deadline: 29 February 2024)
- Hereditary Breast Cancer and BRCA Genes (Deadline: 29 February 2024)
- Biological Imaging in Tumor Microenvironment (Deadline: 29 February 2024)
- Past, Present and Futher Looking for Therapeutic Management of Pancreatic Ductal Adenocarcinoma (Deadline: 29 February 2024)
- Melanoma: Epigenetic Modification, Molecular Changes, and Precision Targeting (Deadline: 15 March 2024)
- New Advance in Whole Genome Sequencing Analysis for Early Cancer Detection (Deadline: 15 March 2024)
- Head-and-Neck Sarcomas: Exploring Ways for Their Optimal Treatment (Deadline: 31 March 2024)
- Genomic Insights and Translational Opportunities for Human Cancers (Deadline: 31 March 2024)
- Early Diagnosis and Targeted Therapy of Pancreatic Cancer (Deadline: 31 March 2024)
- Mitochondria and Immunometabolism in Cancer (Deadline: 31 March 2024)
- Molecular and Pharmacological Basis of Breast Cancer Resistance to Therapies (Deadline: 31 March 2024)
- Endocrine Cancers: Pathophysiology and Therapy (Deadline: 31 March 2024)
- Advances in Cancer Biology and Experimental Anticancer Therapies (Deadline: 30 April 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Autophagy in Cancer and Metastasis
- Feature Papers in Cancer Biology and Therapeutics
- Hereditary Gastrointestinal Cancer Syndromes: Molecular Basis of Onset and Progression, Molecular Diagnosis, and Precision Therapy
- Stem Cells and Cancer Therapeutics (Closed)
- Targeting Cell Metabolism as Cancer Therapy
